Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 09:33 am Purchase | 2025-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | WELLINGTON MANAGEMENT GROUP LLP | 8,381,991 8.900% | 2,574,683 (+44.34%) | Filing History |
| 2025-09-08 5:36 pm Purchase | 2025-08-29 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Farallon Capital Partners, L.P. | 5,625,098 6.000% | 5,625,098 (New Position) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | WELLINGTON MANAGEMENT GROUP LLP | 5,807,308 6.200% | -1,143,259 (-16.45%) | Filing History |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 13,957,269 15.000% | 4,325,631 (+44.91%) | Filing History |
| 2025-04-07 11:52 am Purchase | 2025-03-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | VANGUARD GROUP INC | 9,311,600 10.000% | 222,209 (+2.44%) | Filing History |
| 2025-02-10 10:25 am Purchase | 2024-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | WELLINGTON MANAGEMENT GROUP LLP | 6,950,567 7.500% | 2,490,876 (+55.85%) | Filing History |
| 2025-02-07 10:23 am Purchase | 2025-01-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 9,631,638 10.400% | 727,552 (+8.17%) | Filing History |
| 2025-02-07 10:06 am Purchase | 2024-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 8,904,086 9.600% | 4,860,221 (+120.19%) | Filing History |
| 2025-01-30 9:33 pm Purchase | 2024-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | VANGUARD GROUP INC | 9,089,391 9.800% | 2,801,736 (+44.56%) | Filing History |
| 2024-11-14 7:55 pm Sale | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 2,300,643 2.900% | -1,116,257 (-32.67%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital, LLC | 4,288,120 4.800% | 132,745 (+3.19%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | T. Rowe Price Associates, Inc. | 4,944,757 6.200% | 4,944,757 (New Position) | Filing History |
| 2024-11-12 2:26 pm Unchanged | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | VANGUARD GROUP INC | 6,287,655 7.850% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | WELLINGTON MANAGEMENT GROUP LLP | 4,459,691 5.570% | 1,214,586 (+37.43%) | Filing History |
| 2024-11-04 11:20 am Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | VANGUARD GROUP INC | 6,287,655 7.850% | 2,785,203 (+79.52%) | Filing History |
| 2024-10-17 12:47 pm Sale | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | STATE STREET CORP STT | 2,838,484 3.600% | -725,252 (-20.35%) | Filing History |
| 2024-03-11 3:34 pm Purchase | 2024-02-28 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital, LLC | 4,155,375 5.300% | 4,155,375 (New Position) | Filing History |
| 2024-03-01 8:05 pm Sale | 2023-05-24 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 1,488,703 1.900% | -3,844,829 (-72.09%) | Filing History |
| 2024-02-14 6:36 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | ORBIMED ADVISORS LLC | 1,667,360 2.500% | -1,529,516 (-47.84%) | Filing History |
| 2024-02-14 4:14 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 3,416,900 5.100% | -311,052 (-8.34%) | Filing History |